<?xml version="1.0"?>
<Articles JournalTitle="Frontiers in Biomedical Technologies">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Frontiers in Biomedical Technologies</JournalTitle>
      <Issn>2345-5837</Issn>
      <Volume>11</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="epublish">
        <Year>2024</Year>
        <Month>01</Month>
        <Day>01</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Current Challenges and New Opportunities of Hybrid Nanoparticles for Diagnosis and Treatment of Cancer</title>
    <FirstPage>1</FirstPage>
    <LastPage>5</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Ali</FirstName>
        <LastName>Tarighatnia</LastName>
        <affiliation locale="en_US">Department of Medical Physics, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Golshan</FirstName>
        <LastName>Mahmoudi</LastName>
        <affiliation locale="en_US">Medical Imaging Technology Department, School of Allied Medical Sciences, Shahroud University of Medical Sciences, Shahroud, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mahnaz</FirstName>
        <LastName>Kiani</LastName>
        <affiliation locale="en_US">Research Center for Molecular and Cellular Imaging, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Nader</FirstName>
        <LastName>Nader</LastName>
        <affiliation locale="en_US">University at Buffalo, Jacobs School of Medicine and Biomedical Sciences</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2023</Year>
        <Month>09</Month>
        <Day>05</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2023</Year>
        <Month>09</Month>
        <Day>12</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Hybrid nanoparticles have emerged as promising tools in cancer diagnosis and treatment, offering the potential for early detection and precise eradication of malignant cells by integrating diverse materials. However, navigating the intricacies, limitations, and hurdles within this domain underscores the importance of thoughtful decision-making. This editorial provides a comprehensive exploration of the merits and challenges of nanotechnology in the context of cancer diagnosis, therapy, and theranostics. It sheds light on the current applications and delves into the promising future prospects in this field. By doing so, this editorial aims to foster a deeper understanding of the intricacies involved in designing efficient protocols for hybrid nanoparticle production, contributing to advancing cancer management strategies.</abstract>
    <web_url>https://fbt.tums.ac.ir/index.php/fbt/article/view/817</web_url>
    <pdf_url>https://fbt.tums.ac.ir/index.php/fbt/article/download/817/353</pdf_url>
  </Article>
</Articles>
